EU Council support for cross-border care oversight
This article was originally published in Clinica
The EU Health Council sees new research and telematics programmes as potential useful tools to help explore issues concerning the mobility of patients in Europe. Patient mobility and the desire to have access to high quality health services is a reality creating more interaction between the health systems of the EU, it stated at the Health Council meeting in Luxembourg on June 26. It therefore welcomes the work on creating a simplified framework to support this, recognising that patient mobility presents particular challenges in terms of the need to exchange clinical and other information to ensure proper follow-up and continuity of care.
You may also be interested in...
Liquid biopsy start-up Grail Inc. announced that a study of almost 6,700 participants found that its blood test could detect more than 50 types of cancer with a low false-positive rate. See what Minetta Liu, study co-lead author and a Mayo Clinic professor of oncology, had to say about the research.
Sanofi’s next-generation meningococcal vaccine, broader use of Bristol-Myers Squibb’s Reblozyl move toward approval; United Therapeutics foreshadows Trevyent regulatory difficulties.
Biopharma is working on a reputation renaissance as the public looks to industry for treatments and vaccines for the COVID-19 epidemic and drug pricing concerns take a back seat.